Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
No Borrowings in the last few periods;
Other Long Term Liabilities
YoY Growth in year ended Mar 2025 is 1,283.09% vs -24.66% in Mar 2024
Fixed Assets
YoY Growth in year ended Mar 2025 is -54.52% vs -2.17% in Mar 2024
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2025 is 43.92% vs 11.64% in Mar 2024
Compare Balance Sheet Results of Astrazeneca Phar
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
5.00
81.00
-76.00
-93.83%
Share Warrants & Outstandings
Total Reserve
765.35
2,671.00
-1,905.65
-71.35%
Shareholder's Funds
770.35
2,763.00
-1,992.65
-72.12%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.00
937.00
-937.00
-100.00%
Secured Loans
0.00
0.00
0.00
0.00%
Unsecured Loans
0.00
937.00
-937.00
-100.00%
Deferred Tax Assets / Liabilities
-41.56
-250.00
208.44
83.38%
Other Long Term Liabilities
38.45
195.00
-156.55
-80.28%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
6.32
30.00
-23.68
-78.93%
Total Non-Current Liabilities
3.21
912.00
-908.79
-99.65%
Current Liabilities
Trade Payables
456.30
476.00
-19.70
-4.14%
Other Current Liabilities
140.17
387.00
-246.83
-63.78%
Short Term Borrowings
0.00
590.00
-590.00
-100.00%
Short Term Provisions
106.53
30.00
76.53
255.10%
Total Current Liabilities
703.00
1,483.00
-780.00
-52.60%
Total Liabilities
1,476.56
5,158.00
-3,681.44
-71.37%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
162.41
2,782.00
-2,619.59
-94.16%
Less: Accumulated Depreciation
133.87
1,763.00
-1,629.13
-92.41%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
28.54
1,019.00
-990.46
-97.20%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
79.00
-79.00
-100.00%
Intangible assets under development
0.00
1,181.00
-1,181.00
-100.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.00
297.00
-297.00
-100.00%
Long Term Loans & Advances
69.97
214.00
-144.03
-67.30%
Other Non Current Assets
0.00
121.00
-121.00
-100.00%
Total Non-Current Assets
134.21
3,168.00
-3,033.79
-95.76%
Current Assets Loans & Advances
Current Investments
0.00
422.00
-422.00
-100.00%
Inventories
548.50
426.00
122.50
28.76%
Sundry Debtors
184.88
612.00
-427.12
-69.79%
Cash and Bank
536.70
113.00
423.70
374.96%
Other Current Assets
16.20
85.00
-68.80
-80.94%
Short Term Loans and Advances
56.07
332.00
-275.93
-83.11%
Total Current Assets
1,342.35
1,990.00
-647.65
-32.55%
Net Current Assets (Including Current Investments)
639.35
507.00
132.35
26.10%
Total Current Assets Excluding Current Investments
1,342.35
1,568.00
-225.65
-14.39%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
1,476.56
5,158.00
-3,681.44
-71.37%
Contingent Liabilities
98.41
627.26
-528.85
-84.31%
Total Debt
0.00
1,527.00
-1,527.00
-100.00%
Book Value per share (adjusted)
308.14
170.56
137.58
80.66%
Annual - Borrowings
No Borrowings in the last few periods
No Borrowings in the last few periods;
Annual - Other Long Term Liabilities
Other Long Term Liabilities 38.45 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 1,283.09% vs -24.66% in Mar 2024
Annual - Fixed Assets
Fixed Assets 28.54 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -54.52% vs -2.17% in Mar 2024
Annual - Investments
No Investments in the last few periods
No Investments in the last few periods;
Annual - Current Assets
Current Assets 1,342.35 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 43.92% vs 11.64% in Mar 2024






